4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-002158
CHIEF FINANCIAL OFFICER sold 1,775 shares at $38.05 ($67,547)
- CHIEF FINANCIAL OFFICER gave up 2,037 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 3,812 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kapadia Sandip CHIEF FINANCIAL OFFICER | 2025-01-24 | Option exercise 10b5-1 | +3,812 | 3,812 | D | ||
| Kapadia Sandip CHIEF FINANCIAL OFFICER | 2025-01-24 | Shares withheld for taxes 10b5-1 | −2,037 | $38.01 | $77,426 | 1,775 | D |
| Kapadia Sandip CHIEF FINANCIAL OFFICER | 2025-01-27 | Sale 10b5-1 | −1,775 | $38.05 | $67,547 | 0 | D |
| Derivatives | |||||||
| Kapadia Sandip CHIEF FINANCIAL OFFICER | 2025-01-24 | Option exercise · Restricted Stock Units 10b5-1 | −3,812 | 11,438 | D | ||
| Kapadia Sandip CHIEF FINANCIAL OFFICER | 2025-01-25 | Grant or award · Stock Option 10b5-1 | +66,250 | 66,250 | D | ||
| Kapadia Sandip CHIEF FINANCIAL OFFICER | 2025-01-25 | Grant or award · Restricted Stock Units 10b5-1 | +18,900 | 18,900 | D | ||
| Open-market sales · 1,775 sh · avg $38.05 · $67,547 | |||||||
Loading xslF345X05/form4-01282025_090140.xml…